Adolescents who use tobacco e-cigarettes are significantly more likely to report also using cannabis one year later, according to a new study by researchers at the University of Alabama at Birmingham and the University of Michigan.
Dr Stephen Wright, a consultant in medicines development from Limber Strategic, explores the research behind ketamine.
Three cannabis cultivation companies and one testing lab are facing a class action lawsuit in Arkansas. The allegation? That all four conspired to defraud medical cannabis patients by inflating cannabis potency testing results.
Any cannabis lab analyst that has a unique method for identifying and quantifying pesticides in dried cannabis samples has been invited to submit their technique to AOAC International.
As a result of their findings, the Johns Hopkins Medicine researchers say that improvements need to be made to the regulatory oversight of these products in order to ensure good product quality and prevent unwanted drug effects.
SC Labs is expanding. The Californian cannabis testing lab moved into Michigan and Colorado this year. How is it braving new frontiers when other labs are struggling with the one location? We asked the company’s new CEO, Jeff Journey, and co-founder Josh Wurzer to find out.
To learn more about the app that can diagnose cannabis ailments and discuss what technology advancements like this could mean for cultivators, Analytical Cannabis recently caught up with GrowDoc’s founder and CEO, Daniel Lirette.
A 75-year-old man with Alzheimer’s disease is successfully managing his symptoms with microdoses of cannabis, according to a new case report published in the Journal of Medical Case Reports.
To confirm the findings, the researchers say that additional randomized controlled trials on transdermal CBD for adult focal epilepsy are warranted.